• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations.

作者信息

Swaminathan Rajesh V, East Cara Anne, Feldman Dmitriy N, Fisher Naomi D, Garasic Joseph M, Giri Jay S, Kandzari David E, Kirtane Ajay J, Klein Andrew, Kobayashi Taisei, Koenig Gerald, Li Jun, Secemsky Eric, Townsend Raymond R, Aronow Herbert D

机构信息

Duke University Medical Center, Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.

Baylor Soltero Cardiology Research Center, Dallas, Texas.

出版信息

J Soc Cardiovasc Angiogr Interv. 2023 Aug 21;2(6Part A):101121. doi: 10.1016/j.jscai.2023.101121. eCollection 2023 Nov-Dec.

DOI:10.1016/j.jscai.2023.101121
PMID:39129887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11307723/
Abstract
摘要

相似文献

1
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations.SCAI关于高血压肾去神经支配的立场声明：患者选择、术者能力、培训与技术以及组织建议
J Soc Cardiovasc Angiogr Interv. 2023 Aug 21;2(6Part A):101121. doi: 10.1016/j.jscai.2023.101121. eCollection 2023 Nov-Dec.
2
2022 Renal denervation therapy for the treatment of hypertension: a statement from the Thai Hypertension Society.2022 年经导管去肾交感神经术治疗高血压：泰国高血压学会立场声明。
Hypertens Res. 2023 Apr;46(4):898-912. doi: 10.1038/s41440-022-01133-6. Epub 2023 Feb 9.
3
Consensus and inconsistency between different consensus documents on renal denervation worldwide: the way forward.全球不同肾去神经共识文件之间的一致性和不一致性：前进的方向。
Chin Med J (Engl). 2022 Dec 20;135(24):2926-2937. doi: 10.1097/CM9.0000000000002109.
4
5
Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium.亚洲肾去神经治疗：亚洲肾去神经治疗联盟共识声明。
Hypertension. 2020 Mar;75(3):590-602. doi: 10.1161/HYPERTENSIONAHA.119.13671. Epub 2020 Feb 3.
6
[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].[介入性肾交感神经去神经术治疗高血压专家共识声明]
Dtsch Med Wochenschr. 2011 Nov;136(47):2418. doi: 10.1055/s-0031-1272580. Epub 2011 Nov 2.
7
Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.肾脏去神经治疗难治性高血压：加拿大高血压教育计划的立场声明。
Can J Cardiol. 2014 Jan;30(1):16-21. doi: 10.1016/j.cjca.2013.07.008. Epub 2013 Oct 23.
8
Cardiovascular and Interventional Radiological Society of Europe (CIRSE) position statement on renal denervation for resistant hypertension.欧洲心血管和介入放射学会（CIRSE）关于顽固性高血压肾脏去神经支配的立场声明。
Cardiovasc Intervent Radiol. 2014 Feb;37(1):11-2. doi: 10.1007/s00270-013-0767-z. Epub 2013 Nov 13.
9
ESH position paper: renal denervation - an interventional therapy of resistant hypertension.ESH 立场文件：肾脏去神经术——一种治疗耐药性高血压的介入疗法。
J Hypertens. 2012 May;30(5):837-41. doi: 10.1097/HJH.0b013e328352ce78.
10
[Renal denervation for the treatment of resistant hypertension: definition, patient selection and description of the procedure. 2012 Position paper of the Italian Society of Hypertension].[肾去神经术治疗顽固性高血压：定义、患者选择及手术描述。意大利高血压学会2012年立场文件]
G Ital Cardiol (Rome). 2012 Dec;13(12):846-52. doi: 10.1714/1188.13169.

引用本文的文献

1
Sympathetic Nervous System in Heart Failure: Targets for Treatments.心力衰竭中的交感神经系统：治疗靶点
Curr Hypertens Rep. 2025 Jul 21;27(1):20. doi: 10.1007/s11906-025-01337-4.
2
Cost-Effectiveness of Radiofrequency Renal Denervation in Taiwan Based on Clinical Evidence and Regional Event Rates.基于临床证据和地区事件发生率的台湾地区肾动脉射频消融术的成本效益分析
J Clin Hypertens (Greenwich). 2025 Jun;27(6):e70090. doi: 10.1111/jch.70090.
3
Renal Denervation After USA FDA Approval: An Update from an Interventional Cardiologist's Perspective.

本文引用的文献

1
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.2023年美国心脏病学会/美国心脏协会/心血管造影和介入学会介入心脏病学高级培训声明（冠状动脉、外周血管和结构性心脏病介入治疗）：美国心脏病学会能力管理委员会报告
JACC Cardiovasc Interv. 2023 May 22;16(10):1239-1291. doi: 10.1016/j.jcin.2023.04.011. Epub 2023 Apr 26.
2
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials.超声去肾神经术在 RADIANCE II、RADIANCE-HTN SOLO 和 RADIANCE-HTN TRIO 试验的患者水平汇总分析。
JAMA Cardiol. 2023 May 1;8(5):464-473. doi: 10.1001/jamacardio.2023.0338.
3
美国食品药品监督管理局（FDA）批准后的肾去神经支配：介入心脏病专家视角的最新进展
J Clin Med. 2025 May 19;14(10):3554. doi: 10.3390/jcm14103554.
4
Evaluating Veterans' Preferences for Renal Denervation for Treatment of Difficult-to-Control Hypertension: A Single-Center Survey Study.评估退伍军人对肾去神经支配治疗难治性高血压的偏好：一项单中心调查研究。
Health Sci Rep. 2025 Mar 10;8(3):e70549. doi: 10.1002/hsr2.70549. eCollection 2025 Mar.
5
Key Updates to the 2024 ESC Hypertension Guidelines and Future Perspectives.《2024年欧洲心脏病学会高血压指南的关键更新及未来展望》
Medicina (Kaunas). 2025 Jan 23;61(2):193. doi: 10.3390/medicina61020193.
6
Renal denervation for hypertension.用于治疗高血压的肾去神经支配术。
Nat Rev Cardiol. 2025 Jan 2. doi: 10.1038/s41569-024-01104-z.
7
Renal Denervation: New Evidence Supporting Long-Term Efficacy, Alternative Access Routes, and Cost-Effectiveness.肾去神经支配：支持长期疗效、替代入路及成本效益的新证据
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1528-1530. doi: 10.1111/jch.14945. Epub 2024 Nov 25.
8
Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials.定义高血压介入治疗反应者的新方法：来自SPYRAL HTN-OFF和HTN-ON MED试验的见解
Hypertens Res. 2025 Jan;48(1):327-335. doi: 10.1038/s41440-024-01949-4. Epub 2024 Nov 14.
9
Device therapies for heart failure with reduced ejection fraction: a new era.射血分数降低的心力衰竭的器械治疗：一个新时代。
Front Cardiovasc Med. 2024 Oct 18;11:1388232. doi: 10.3389/fcvm.2024.1388232. eCollection 2024.
10
Renal Denervation Lowers Nighttime Blood Pressure in True Resistant Hypertension.肾去神经支配可降低真性顽固性高血压患者的夜间血压。
Hypertension. 2024 Dec;81(12):e200-e202. doi: 10.1161/HYPERTENSIONAHA.124.23848. Epub 2024 Oct 21.
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.血管内超声肾脏去神经治疗高血压：RADIANCE II 随机临床试验。
JAMA. 2023 Feb 28;329(8):651-661. doi: 10.1001/jama.2023.0713.
4
Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment.患者对未控制高血压的药物和器械治疗的偏好：离散选择实验。
Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e008997. doi: 10.1161/CIRCOUTCOMES.122.008997. Epub 2022 Dec 9.
5
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.强化血压控制的长期全因和心血管死亡率：一项随机临床试验的二次分析。
JAMA Cardiol. 2022 Nov 1;7(11):1138-1146. doi: 10.1001/jamacardio.2022.3345.
6
Translational value of preclinical models for renal denervation: a histological comparison of human versus porcine renal nerve anatomy.临床前模型在肾脏去神经支配中的转化价值：人类与猪肾脏神经解剖结构的组织学比较。
EuroIntervention. 2023 Feb 6;18(13):e1120-e1128. doi: 10.4244/EIJ-D-22-00369.
7
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.基于导管的肾动脉去神经术治疗耐药性高血压的长期结果：随机 SYMPLICITY HTN-3 试验的最终随访。
Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18.
8
Medication adherence in hypertension: lessons learned from renal denervation trials.高血压治疗中的药物依从性：肾去神经支配试验的经验教训。
Eur J Prev Cardiol. 2023 Jan 11;30(1):34-36. doi: 10.1093/eurjpc/zwac159.
9
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.在使用抗高血压药物的情况下肾动脉去神经术的长期疗效和安全性（SPYRAL HTN-ON MED）：一项随机、假手术对照试验。
Lancet. 2022 Apr 9;399(10333):1401-1410. doi: 10.1016/S0140-6736(22)00455-X. Epub 2022 Apr 4.
10
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.基于器械的高血压治疗临床试验设计原则和结局定义：高血压学术研究联合会共识文件。
Circulation. 2022 Mar 15;145(11):847-863. doi: 10.1161/CIRCULATIONAHA.121.057687. Epub 2022 Mar 14.